The Trump administration is reportedly considering an executive order focused on vaccines and autism, with a possible release as soon as next week. Reports, first published by the Washington Post and echoed by other outlets, say the action would direct new attention and resources to autism research and to review the childhood vaccine schedule.
A White House spokesperson, Kush Desai, framed the effort as responding to parents’ questions about vaccination and said the administration is committed to pursuing high-quality science on the issue. Officials have not confirmed final scope or timing, and details could change. The reported push follows a 2025 directive that asked the Centers for Disease Control and Prevention to study the contested autism-vaccine link.
The proposed order comes despite a broad scientific consensus that childhood vaccines do not cause autism. Large-scale research — including a recent study of more than 2.5 million U.S. children — has found no association between the timing of the first measles-mumps-rubella (MMR) shot before age 2 and a later autism diagnosis. Researchers and medical societies say earlier studies that suggested a link were flawed and have been discredited.
Pediatricians and public-health experts stress that vaccines are safe, effective, and crucial for preventing serious infectious diseases. They urge parents to discuss questions and concerns with their child’s pediatrician and to consult trusted sources such as professional medical associations for up-to-date information on recommended vaccine schedules.
Experts also warn about the public-health consequences of vaccine hesitancy. Declines in childhood vaccination rates have been linked to resurgences of infections like measles, and clinicians say adherence to recommended schedules helps protect both individual children and the wider community. Several pediatric leaders quoted by reporters emphasized that vaccines’ long history of success can make the risks of those diseases easy to forget — which can weaken support for vaccination.
The administration has engaged vocal critics of vaccination in discussions about vaccine safety, and Health and Human Services declined to comment for reports on the possible order. Supporters of the executive action say it responds to parental concerns and seeks more research; critics say it risks legitimizing debunked claims and could fuel vaccine hesitancy.
This is a developing story. Additional details and official statements may follow as the administration finalizes any order and outlines its research priorities and implementation plans.
